The9 investee NYB plans $1.5 billion SPAC merger to go public

October 2, 2025 7:30 AM EDT Send to a Friend
The9 Limited (NASDAQ: NCTY) announced that its Singapore investee Nanyang Biologics Pte. Ltd. (NYB) entered into a business combination agreement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login